Pregabalin improves axon regeneration and motor outcome in a rodent stroke model.
Christof KuglerNelli BlankHana MatuskovaChristian ThielscherNicole ReichenbachTien-Chen LinFrank BradkeGabor C PetzoldPublished in: Brain communications (2022)
Ischaemic stroke remains a leading cause of death and disability worldwide. Surviving neurons in the peri-infarct area are able to establish novel axonal projections to juxtalesional regions, but this regeneration is curtailed by a growth-inhibitory environment induced by cells such as reactive astrocytes in the glial scar. Here, we found that the astroglial synaptogenic cue thrombospondin-1 is upregulated in the peri-infarct area, and hence tested the effects of the anticonvulsant pregabalin, a blocker of the neuronal thrombospondin-1 receptor Alpha2delta1/2, in a mouse model of cortical stroke. Studying axonal projections after cortical stroke in mice by three-dimensional imaging of cleared whole-brain preparations, we found that pregabalin, when administered systemically for 5 weeks after stroke, augments novel peri-infarct motor cortex projections and improves skilled forelimb motor function. Thus, the promotion of axon elongation across the glial scar by pregabalin represents a promising target beyond the acute phase after stroke to improve structural and functional recovery.
Keyphrases
- neuropathic pain
- spinal cord injury
- spinal cord
- atrial fibrillation
- cerebral ischemia
- postoperative pain
- stem cells
- acute myocardial infarction
- mouse model
- wound healing
- optic nerve
- induced apoptosis
- high resolution
- white matter
- cell cycle arrest
- cell death
- type diabetes
- coronary artery disease
- adipose tissue
- left ventricular
- subarachnoid hemorrhage
- percutaneous coronary intervention
- acute coronary syndrome
- metabolic syndrome
- photodynamic therapy
- insulin resistance
- fluorescence imaging
- high fat diet induced